Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
Google Secures Pentagon AI Deal for Classified Projects 
MINNEAPOLIS, May 04, 2017 -- GWG Holdings, Inc. (Nasdaq:GWGH), the parent company of GWG Life, a financial services company committed to transforming the life insurance industry through disruptive and innovative products and services, announced it has completed its exclusive license with the University of California, Los Angeles (UCLA) for the “DNA Methylation Based Predictor of Mortality” technology for application to the life insurance and related industries.
The technology, invented by Dr. Steve Horvath, a professor of human genetics at the David Geffen School of Medicine at UCLA, provides life expectancy estimates based upon epigenetic biomarkers. Epigenetics differs from genetics in that epigenetics do not include changes to the genetic sequence. GWG Holdings announced previously that it had optioned the technology in November to begin developing a commercial application of the technology’s ability to deliver more accurate life expectancy projections for the life insurance industry. Since that time, GWG Life has been actively pursuing the commercialization of the epigenetic-based technology in what is called: “M-Panel” technology. The M-Panel technology measures the methylation of CpG sites identified by Dr. Horvath as biomarkers indicative of biological aging.
In February, GWG Life announced that it began collecting and analyzing epigenetic data from policyholders selling their life insurance. Dr. Brian Chen, the company’s Vice President of Research and Analytics, is continuing research on the relationship between epigenetics and aging. Dr. Chen is first author on the breakthrough study titled “DNA methylation‐based measures of biological age: Meta‐analysis predicting time to death” published in the scientific journal Aging.
Since Dr. Horvath’s discovery of the concept of biological age in 2014, Dr. Chen continues to grow more confident about the test’s correlation to an assessment of the aging process. “Many researchers who were once skeptical about its utility have been surprised at how well it works across different samples,” Dr. Chen said. “Even though we’ve only scratched the surface, epigenetics are already showing much more promise for assessing human health than merely looking at the genetic sequence.”
About GWG Holdings, Inc.
GWG Holdings, Inc. (Nasdaq:GWGH) the parent company of GWG Life, is a financial services company committed to transforming the life insurance industry through disruptive and innovative products and services. Already a recognized disruptor in the life insurance secondary market, GWG Life seeks to further transform the industry by continuing to create innovative products and services. As of December 31, 2016, GWG Life’s growing portfolio consisted of over $1.36 billion in face value of policy benefits. Since 2006, GWG Life has purchased over $2.3 billion in life insurance policy benefits and paid seniors more than $398 million for their life insurance.
For more information about GWG Holdings, email [email protected] or visit www.gwgh.com.
Media contacts: Dan Callahan GWG Holdings, Inc. (612) 746-1935 [email protected] Matt Ehlers G&S Business Communications (919) 870-5718, x3221 [email protected]
